papaverine has been researched along with Syndrome in 5 studies
Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate coronary vasodilatory reserve in syndrome X, left coronary arteriography and continuous measurement of coronary venous oxygen saturation (CSO2-Sat) were performed during intracoronary injection of papaverine (PAP) and acetylcholine (ACh) in 11 patients of syndrome X and 13 control subjects." | 7.68 | [Coronary vasodilation during intracoronary injection of papaverine and acetylcholine in syndrome X: evaluation by coronary arteriograms and coronary venous oxygen saturation dynamics]. ( Fujino, Y; Hanadate, Y; Mikuniya, A; Miura, T; Mori, Y; Narita, T; Onodera, K; Satoh, M; Takahashi, M; Wada, K, 1993) |
| "To evaluate coronary vasodilatory reserve in syndrome X, left coronary arteriography and continuous measurement of coronary venous oxygen saturation (CSO2-Sat) were performed during intracoronary injection of papaverine (PAP) and acetylcholine (ACh) in 11 patients of syndrome X and 13 control subjects." | 3.68 | [Coronary vasodilation during intracoronary injection of papaverine and acetylcholine in syndrome X: evaluation by coronary arteriograms and coronary venous oxygen saturation dynamics]. ( Fujino, Y; Hanadate, Y; Mikuniya, A; Miura, T; Mori, Y; Narita, T; Onodera, K; Satoh, M; Takahashi, M; Wada, K, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| NEUBUERGER, KT | 1 |
| FREED, CG | 1 |
| DENST, J | 1 |
| Shafik, A | 1 |
| Ahmed, I | 1 |
| El Sibai, O | 1 |
| Shafik, AA | 1 |
| Ostrakhovich, AN | 1 |
| Strelkova, NI | 1 |
| Fujino, Y | 1 |
| Mikuniya, A | 1 |
| Narita, T | 1 |
| Takahashi, M | 1 |
| Satoh, M | 1 |
| Mori, Y | 1 |
| Wada, K | 1 |
| Miura, T | 1 |
| Hanadate, Y | 1 |
| Onodera, K | 1 |
| Sobolev, LV | 1 |
| Biriukov, VA | 1 |
| Morozov, AI | 1 |
1 trial available for papaverine and Syndrome
| Article | Year |
|---|---|
[Cerebral hemodynamics in the intravenous administration of papaverine in cervical osteochondrosis].
Topics: Adolescent; Adult; Aged; Cerebrovascular Circulation; Clinical Trials as Topic; Drug Evaluation; Fem | 1979 |
4 other studies available for papaverine and Syndrome
| Article | Year |
|---|---|
Vasal component in syndrome of Foix Alajouanine; subacute necrotizing myelitis.
Topics: Humans; Myelitis; Myelitis, Transverse; Papaverine; Syndrome | 1953 |
The hypoactive corpora cavernosa with degenerative erectile dysfunction: a new syndrome.
Topics: Adult; Electromyography; Erectile Dysfunction; Humans; Male; Middle Aged; Muscle, Smooth; Papaverine | 2006 |
[Treatment of patients with neurologic syndromes of cervical osteochondrosis by electrophoresis of papaverine and nicotinic acid using sinusoidally-modulated and diadynamic currents].
Topics: Administration, Oral; Adolescent; Adult; Aged; Blood Circulation; Cervical Vertebrae; Female; Humans | 1982 |
[Coronary vasodilation during intracoronary injection of papaverine and acetylcholine in syndrome X: evaluation by coronary arteriograms and coronary venous oxygen saturation dynamics].
Topics: Acetylcholine; Adult; Aged; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary V | 1993 |